Search research articles
Contact Us
Filters
Showing results (71-80 of 101) with videos related to
Page
of 11
Sort By:
Patient Education and Counseling
|
September 20, 2024
Health literacy and the use of digital tools in older patients with cancer and their younger counterparts: A multicenter, nationwide study
Elena Paillaud, Angéline Galvin, Solène Doublet, et al.
JCO Precision Oncology
|
October 31, 2022
Implementing the European Society for Medical Oncology Scale for Clinical Actionability of Molecular Targets in a Comprehensive Profiling Program: Impact on Precision Medicine Oncology
Patricia Martin-Romano, Laura Mezquita, Antoine Hollebecque, et al.
JCO Precision Oncology
|
May 30, 2024
Impact of Clonal Hematopoiesis-Associated Mutations in Phase I Patients Treated for Solid Tumors: An Analysis of the STING Trial
Julieta Rodriguez, Capucine Baldini, Arnaud Bayle, et al.
Cancers
|
September 9, 2022
BMS-986158, a Small Molecule Inhibitor of the Bromodomain and Extraterminal Domain Proteins, in Patients with Selected Advanced Solid Tumors: Results from a Phase 1/2a Trial
John Hilton, Mihaela Cristea, Sophie Postel-Vinay, et al.
Neurology
|
September 30, 2022
In Vivo 2-Hydroxyglutarate Monitoring With Edited MR Spectroscopy for the Follow-up of <i>IDH</i>-Mutant Diffuse Gliomas: The <i>IDASPE</i> Prospective Study
Anna Luisa Di Stefano, Lucia Nichelli, Giulia Berzero, et al.
Current Oncology Reports
|
July 27, 2024
Exploring the Role of Target Expression in Treatment Efficacy of Antibody-Drug Conjugates (ADCs) in Solid Cancers: A Comprehensive Review
Laurent Mathiot, Capucine Baldini, Octave Letissier, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 11, 2024
Reactions and adverse events induced by T-cell engagers as anti-cancer immunotherapies, a comprehensive review
Arthur Géraud, Thomas Hueso, Ariane Laparra, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 27, 2026
Acute kidney injury in patients included in early-phase oncology clinical trials, results of the AKITEP study
Matthieu Delaye, Paul Matte, Adrien Mouren, et al.
Brain Communications
|
October 15, 2021
Neurological complications induced by immune checkpoint inhibitors: a comprehensive descriptive case-series unravelling high risk of long-term sequelae
Léo Plaçais, Jean-Marie Michot, Stéphane Champiat, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 20, 2022
Feasibility, safety and efficacy of human intra-tumoral immuno-therapy. Gustave Roussy's initial experience with its first 100 patients
Lambros Tselikas, Antoine Dardenne, Thierry de Baere, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 101) with videos related to
Sort By:
Page
of 11
Patient Education and Counseling
|
September 20, 2024
Health literacy and the use of digital tools in older patients with cancer and their younger counterparts: A multicenter, nationwide study
Elena Paillaud, Angéline Galvin, Solène Doublet, et al.
JCO Precision Oncology
|
October 31, 2022
Implementing the European Society for Medical Oncology Scale for Clinical Actionability of Molecular Targets in a Comprehensive Profiling Program: Impact on Precision Medicine Oncology
Patricia Martin-Romano, Laura Mezquita, Antoine Hollebecque, et al.
JCO Precision Oncology
|
May 30, 2024
Impact of Clonal Hematopoiesis-Associated Mutations in Phase I Patients Treated for Solid Tumors: An Analysis of the STING Trial
Julieta Rodriguez, Capucine Baldini, Arnaud Bayle, et al.
Cancers
|
September 9, 2022
BMS-986158, a Small Molecule Inhibitor of the Bromodomain and Extraterminal Domain Proteins, in Patients with Selected Advanced Solid Tumors: Results from a Phase 1/2a Trial
John Hilton, Mihaela Cristea, Sophie Postel-Vinay, et al.
Neurology
|
September 30, 2022
In Vivo 2-Hydroxyglutarate Monitoring With Edited MR Spectroscopy for the Follow-up of <i>IDH</i>-Mutant Diffuse Gliomas: The <i>IDASPE</i> Prospective Study
Anna Luisa Di Stefano, Lucia Nichelli, Giulia Berzero, et al.
Current Oncology Reports
|
July 27, 2024
Exploring the Role of Target Expression in Treatment Efficacy of Antibody-Drug Conjugates (ADCs) in Solid Cancers: A Comprehensive Review
Laurent Mathiot, Capucine Baldini, Octave Letissier, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 11, 2024
Reactions and adverse events induced by T-cell engagers as anti-cancer immunotherapies, a comprehensive review
Arthur Géraud, Thomas Hueso, Ariane Laparra, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 27, 2026
Acute kidney injury in patients included in early-phase oncology clinical trials, results of the AKITEP study
Matthieu Delaye, Paul Matte, Adrien Mouren, et al.
Brain Communications
|
October 15, 2021
Neurological complications induced by immune checkpoint inhibitors: a comprehensive descriptive case-series unravelling high risk of long-term sequelae
Léo Plaçais, Jean-Marie Michot, Stéphane Champiat, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 20, 2022
Feasibility, safety and efficacy of human intra-tumoral immuno-therapy. Gustave Roussy's initial experience with its first 100 patients
Lambros Tselikas, Antoine Dardenne, Thierry de Baere, et al.
Page
of 11